Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres-Reference-Cited by-同舟云学术

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres

Published:2008-10-31 Issue:22 Volume:53 Page:6591-6603
ISSN:0031-9155
Container-title:Physics in Medicine and Biology
language:
Short-container-title:Phys. Med. Biol.

Author:

Flamen Patrick,Vanderlinden Bruno,Delatte Philippe,Ghanem Ghanem,Ameye Lieveke,Eynde Marc Van Den,Hendlisz Alain

Publisher

IOP Publishing

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference31 articles.

1. 90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT

2. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation

3. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a preliminary machine learning study;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-09

2. Radioembolisation mit Harz- und Glas-Mikrosphären;Radiopraxis;2024-05-31

3. Fabrication of quantum dot-immobilized Y ₂ O ₃ microspheres with effective photoluminescence for cancer radioembolization therapy;Science and Technology of Advanced Materials;2024-04-02

4. Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment;Journal of Gastrointestinal Oncology;2024-02

5. Embolization of Metastatic Liver Disease;Interventional Oncology;2024